Struggling Pfizer's research chief and CFO to leave by end of year

Pfizer Chief Executive Jeffrey Kindler proved even those at the top aren't immune to an ongoing company-wide transformation late Sunday in announcing the departure of Research and Development President John LaMattina and Chief Financial Officer Alan Levin.

Leave a Reply

Your email address will not be published. Required fields are marked *